Spontaneous Remission and Concomitant Progression in a Patient with DLBCL

Diagnostics
Eun Ji HanJoo Hyun O

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. Although DLBCL can be cured in more than half of all patients, up to 50% of patients become refractory to initial treatment or relapse after complete remission. We present a case of complete spontaneous remission of some tumors and concomitant newly developed tumors observed in a patient with relapsed DLBCL. Spontaneous remission of lymphoma without treatment is a rare phenomenon and can occur at baseline as well as in relapsed DLBCL. However, most patients who initially experience spontaneous remission later develop relapse. Thus, careful follow-up is required, and fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) allows monitoring of multiple lesions.

References

May 15, 1980·Cancer·H H GattikerD A Galton
Jun 19, 2016·International Journal of Surgery Case Reports·Jun SasakiAkira Sasaki
Nov 24, 2017·Pathology·Shaoying LiL Jeffrey Medeiros
Apr 17, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G IacoboniA Stathis
Nov 16, 2018·Acta Haematologica·Oren PasvolskyLiat Vidal
Feb 3, 2019·Journal of Medical Case Reports·J SnijderG Rivero

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

[Rinshō ketsueki] The Japanese journal of clinical hematology
Taichi HiranoHiroyuki Tsuda
[Rinshō ketsueki] The Japanese journal of clinical hematology
Ken Ohmachi
Hematology/oncology Clinics of North America
Anas Younes
© 2021 Meta ULC. All rights reserved